Mary Lee

Mary Lee is a freelance writer and journalist based in Toronto, Canada. She holds an M.S. degree in business and economic journalism from Columbia University’s Graduate School of Journalism in New York and a certificate in digital marketing from the University of Toronto.

Mary Lee
SGMT stock news

Sagimet Biosciences (NASDAQ: SGMT) Stock Skyrockets on Positive Denifanstat Trial Results

Shares of Sagimet Biosciences (NASDAQ: SGMT) skyrocketed 154% in the afternoon trading Monday following the release of positive topline results from Phase 2b FASCINATE-2 clinical trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH. Sagimet Biosciences (NASDAQ: SGMT) has shared some great

Sagimet Biosciences (NASDAQ: SGMT) Stock Skyrockets on Positive Denifanstat Trial Results Read More »

ELAB stock news

Elevai Labs (NASDAQ: ELAB) Stock Plunges Post-Acquisition of Proprietary Stem Cell Manufacturing License

Elevai Labs (NASDAQ: ELAB) stock plummeted nearly 19% on Tuesday following the acquisition of the Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology. Elevai Labs (ELAB) has signed an exclusive worldwide manufacturing and processing technology licensing agreement with INmune

Elevai Labs (NASDAQ: ELAB) Stock Plunges Post-Acquisition of Proprietary Stem Cell Manufacturing License Read More »